Jyong Biotech Ltd. (MENS) Stock Price & Analysis

32 Followers

MENS Stock Chart & Stats

$1.74-$0.05(-2.79%)

At close: Nov 11 4:00 PM EST

Day’s Range: $1.66 - $1.83
52-Week Range: $1.43 - $40.57
Previous Close: $1.79
Volume: N/A
Average Volume (3M): 42.33K
Market Cap: $132.88M
Enterprise Value: $139.02T
Total Cash (Recent Filing): $1.18M
Total Debt (Recent Filing): $18.55M
Price to Earnings (P/E): ―
Beta: 2.25
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Jyong Biotech Ltd. News

Jyong Biotech Delays Annual 20-F (Yearly Report)

Jyong Biotech Ltd. ( ($MENS) ) has released a notification of late filing. Jyong Biotech Ltd. has filed a Form 12b-25, notifying investors of a delay in submitting its Form

6M agoMENS

Jyong issues strategic corporate update, completes Phase II trial for MCS-8

Jyong Biotech (MENS) issued a strategic corporate update. This review encapsulates a pivotal period characterized by the successful completion of the Phase II clinical trial for its lead candidate, MCS-8,

9M agoMENS

Jyong Biotech Appoints Veteran Capital Markets Executive Wei Zhang as Chief Financial Officer

Jyong Biotech Ltd. ( ($MENS) ) has issued an update. On February 6, 2026, Jyong Biotech Ltd. announced the appointment of Wei (Vivi) Zhang as its new Chief Financial Officer,

9M ago6K MENS

Jyong Biotech subsidiary announces phase II data for MCS-8

Jyong Biotech (MENS) announced updated statistical analyses for key blood biochemical markers from its Phase II clinical trial of MCS-8 conducted in Taiwan. The results underscore MCS-8’s previously indicated multifaceted

9M agoMENS

Ten new option listings and two option delistings on January 22nd

New option listings for January 22nd include Aardvark Therapeutics Inc (AARD), Anteris Technologies Global Corp (AVR), Climb Bio Inc (CLYM), REX Drone ETF (DRNZ), Grace Therapeutics, Inc (GRCE), Infinity Natural

9M agoAVR INR

Jyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited Results

The latest update is out from Jyong Biotech Ltd. ( ($MENS) ). On January 9, 2026, Jyong Biotech Ltd. furnished unaudited interim condensed consolidated financial statements for the six months

10M ago6K MENS

Jyong Biotech ‘not aware’ of any material information amid share price movement

Jyong Biotech (MENS) noted the recent fluctuation in its share price and the increased trading volume of its shares on the Nasdaq Stock Exchange following the expiry of the lock-up

10M agoMENS

Jyong Biotech Ltd trading resumes

11:25 EST Jyong Biotech (MENS) Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks

11M agoMENS

Jyong Biotech Ltd trading halted, volatility trading pause

11:15 EST Jyong Biotech (MENS) Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing

11M agoMENS

Jyong Biotech signs MOU with Vietnam pharmaceutical distributor

Jyong Biotech (MENS) announced that it has entered into a non-binding Memorandum of Understanding, MOU, with a Vietnam-based pharmaceutical distribution company headquartered in Ho Chi Minh City, to evaluate the

11M agoMENS

Jyong Biotech signs non-binding LOI with South Korean pharma company

Jyong Biotech (MENS) entered into a non-binding letter of intent with a South Korean pharmaceutical company to review and evaluate the potential in-licensing and development of Jyong Biotech’s plant-derived new

11M agoMENS

Jyong Biotech completes primary endpoint analysis for Phase II trial of MCS-8

Jyong Biotech (MENS) announced that it has achieved another milestone in the development of its plant-derived new drug MCS-8, PCP. The Company has completed the statistical analysis of the primary

11M agoMENS

Jyong Biotech Ltd trading halted, volatility trading pause

15:55 EDT Jyong Biotech (MENS) Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot

1y agoMENS

MENS FAQ

What was Jyong Biotech Ltd.’s price range in the past 12 months?

Jyong Biotech Ltd. lowest stock price was $1.43 and its highest was $40.57 in the past 12 months.

What is Jyong Biotech Ltd.’s market cap?

Jyong Biotech Ltd.’s market cap is $132.88M.

When is Jyong Biotech Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is Jyong Biotech Ltd. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Jyong Biotech Ltd. pay dividends?

Jyong Biotech Ltd. does not currently pay dividends.

What is Jyong Biotech Ltd.’s EPS estimate?

Jyong Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Jyong Biotech Ltd. have?

Jyong Biotech Ltd. has 76,027,664 shares outstanding.

Which hedge fund is a major shareholder of Jyong Biotech Ltd.?

Hedge funds hold Jyong Biotech Ltd. shares: the largest hedge-fund position in Jyong Biotech Ltd. is 71,885,576 shares, and hedge funds increased their holdings by 1.6K shares last quarter.

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Jyong Biotech Ltd. Stock Smart Score

Underperform

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description